4.7 Article

Circulating Levels of PD-L1, TIM-3 and MMP-7 Are Promising Biomarkers to Differentiate COVID-19 Patients That Require Invasive Mechanical Ventilation

相关参考文献

注意:仅列出部分参考文献,下载原文获取全部文献信息。
Article Respiratory System

Lung Function, Radiological Findings and Biomarkers of Fibrogenesis in a Cohort of COVID-19 Patients Six Months After Hospital Discharge

Belen Safont et al.

Summary: This study evaluated functional respiratory parameters, changes in chest CT, and correlation with peripheral blood biomarkers involved in lung fibrosis at two and six months after SARS-CoV-2 pneumonia. The results showed that almost half of patients with moderate or severe COVID-19 pneumonia had impaired pulmonary diffusion six months after discharge. Severe patients showed fibrotic lesions in CT scan and elevated serum biomarkers involved in pulmonary fibrosis.

ARCHIVOS DE BRONCONEUMOLOGIA (2022)

Article Biology

High Levels of TNF-α and TIM-3 as a Biomarker of Immune Reconstitution Inflammatory Syndrome in People with HIV Infection

Lucero A. Ramon-Luing et al.

Summary: IRIS is an exacerbated immune response that can occur to HIV+ patients after initiating ART treatment. This study found that high levels of soluble TIM-3 and TNF-alpha could serve as biomarkers for IRIS.

LIFE-BASEL (2021)

Article Respiratory System

Risk factors associated with the development of interstitial lung abnormalities

Ivette Buendia-Roldan et al.

Summary: The study found that individuals with ILAs are usually male, older, smokers, and have a higher frequency of the MUC5B rs35705950 variant. They also exhibit differences in lung function and increased levels of pro-inflammatory molecules and MMPs in their serum.

EUROPEAN RESPIRATORY JOURNAL (2021)

Article Respiratory System

CD4+T cells in ageing-associated interstitial lung abnormalities show evidence of pro-inflammatory phenotypic and functional profile

Carlos Machahua et al.

Summary: The study found that in ILA patients, the number of Naive CD4+T cells increased, while the number of central and effector memory CD4+T cells decreased. CD4+T cells in ILA patients were highly proliferative and showed excessive functional activity, likely related to the loss of KLRG1 expression.

THORAX (2021)

Article Hematology

Prevalence and characteristics of pulmonary embolism in 1042 COVID-19 patients with respiratory symptoms: A nested case-control study

Benjamin Planquette et al.

Summary: The study estimated a prevalence of symptomatic PE in COVID-19 patients close to 5%, or up to 20% in clinically suspected cases. PE patients often required invasive ventilation and exhibited more extensive lung damage compared to controls. D-dimer levels were significantly higher in PE patients than controls.

THROMBOSIS RESEARCH (2021)

Review Immunology

Emerging concepts in PD-1 checkpoint biology

Kristen E. Pauken et al.

Summary: The PD-1 pathway is essential in immune regulation, playing diverse roles beyond maintaining T cell exhaustion in chronic infection and cancer. PD-1 blockade impacts various T cell differentiation states, regulates Treg cells, NK cells, and ILCs, and has potential in early-stage cancer treatment.

SEMINARS IN IMMUNOLOGY (2021)

Review Immunology

Cytokine Storm: The Primary Determinant for the Pathophysiological Evolution of COVID-19 Deterioration

Ruirong Chen et al.

Summary: The COVID-19 pandemic poses a major threat to global health, with cytokine storms being a significant cause of disease deterioration and death, making it crucial to understand the pathophysiological processes involved for effective treatment.

FRONTIERS IN IMMUNOLOGY (2021)

Article Cell Biology

PD-L1 Regulates Inflammation in LPS-Induced Lung Epithelial Cells and Vascular Endothelial Cells by Interacting with the HIF-1α Signaling Pathway

Shilong Zhao et al.

Summary: This study found that downregulating PD-L1 can alleviate inflammation in LPS-induced lung epithelial cells and vascular endothelial cells by regulating the HIF-1 alpha signaling pathway. Additionally, the IL-6 inhibitor LMT-28 also has a certain alleviating effect on lung injury.

INFLAMMATION (2021)

Article Immunology

Association of Clinical and Immunological Characteristics With Disease Severity and Outcomes in 211 Patients With COVID-19 in Wuhan, China

Man Wang et al.

Summary: This study investigated the clinical and immunological features of severe and critically severe patients with COVID-19, and identified risk factors for disease severity and clinical outcome. Older age, male sex, underlying illness, sustained fever status, abnormal blood indicators, high IL-6 levels, lymphopenia, and selective loss of peripheral lymphocyte subsets were associated with disease deterioration and clinical outcome in COVID-19 patients. These findings provide valuable information for risk assessment and interventions for COVID-19.

FRONTIERS IN CELLULAR AND INFECTION MICROBIOLOGY (2021)

Article Immunology

PD-L1 Dysregulation in COVID-19 Patients

Francesco Sabbatino et al.

Summary: The COVID-19 pandemic has led to severe social and medical consequences, including a subset of patients with rapidly worsening severe-critical manifestations. Prognostic biomarkers and therapeutic approaches are urgently needed to address this issue. Dysregulated immune response, particularly involving immune checkpoint molecules like PD-1 and PD-L1, play a significant role in COVID-19 pathogenesis. Serum levels of PD-L1 have shown to have a prognostic role in COVID-19 patients, indicating the potential for PD-1/PD-L1 inhibitors in clinical studies.

FRONTIERS IN IMMUNOLOGY (2021)

Article Medicine, Research & Experimental

Immunofibrotic drivers of impaired lung function in postacute sequelae of SARS-CoV-2 infection

Hyung J. Chun et al.

Summary: This study found that biological factors related to neutrophil activation, fibrosis signaling, and alveolar repair may be novel therapeutic or prognostic targets for individuals recovering from COVID-19 with persistent respiratory symptoms.

JCI INSIGHT (2021)

Article Critical Care Medicine

Clinical characteristics and day-90 outcomes of 4244 critically ill adults with COVID-19: a prospective cohort study

Matthieu Schmidt et al.

Summary: Among more than 4000 critically ill patients with COVID-19 admitted to our ICUs, 90-day mortality was 31% and decreased from 42 to 25% over the study period. Mortality was higher in older, diabetic, obese and severe ARDS patients.

INTENSIVE CARE MEDICINE (2021)

Article Medicine, General & Internal

Soluble PD-L1: a potential immune marker for HIV-1 infection and virological failure

Jose Avendano-Ortiz et al.

MEDICINE (2020)

Article Multidisciplinary Sciences

Immunological and inflammatory profiles in mild and severe cases of COVID-19

Jin-Wen Song et al.

NATURE COMMUNICATIONS (2020)

Review Immunology

Tim-3: A co-receptor with diverse roles in T cell exhaustion and tolerance

Ruihan Tang et al.

SEMINARS IN IMMUNOLOGY (2019)

Review Medicine, General & Internal

Programmed death-1 immune checkpoint blockade in the treatment of hematological malignancies

Panagiotis Tsirigotis et al.

ANNALS OF MEDICINE (2016)

Article Medicine, Research & Experimental

Programmed death ligand-1 expression on donor T cells drives graft-versus-host disease lethality

Asim Saha et al.

JOURNAL OF CLINICAL INVESTIGATION (2016)

Review Respiratory System

Role of matrix metalloproteinases in the pathogenesis of idiopathic pulmonary fibrosis

Annie Pardo et al.

RESPIRATORY RESEARCH (2016)

Article Respiratory System

Matrix metalloproteinases in acute lung injury: mediators of injury and drivers of repair

A. Davey et al.

EUROPEAN RESPIRATORY JOURNAL (2011)

Article Immunology

A genomic storm in critically injured humans

Wenzhong Xiao et al.

JOURNAL OF EXPERIMENTAL MEDICINE (2011)

Article Immunology

PD-L1 regulates the development, maintenance, and function of induced regulatory T cells

Loise M. Francisco et al.

JOURNAL OF EXPERIMENTAL MEDICINE (2009)